January 9 2026
Paragraph IV patent challenges let generic drug makers legally fight brand-name patents to speed up cheaper alternatives. This system, created by the Hatch-Waxman Act, saves billions annually and drives 90% of U.S. prescriptions. Here's how it works - and why it matters.
SEE MORE
